Skip to main content

Table 1 Demographic, clinical, and laboratory data of the study population

From: Evaluation of novel coronavirus disease (COVID-19) using quantitative lung CT and clinical data: prediction of short-term outcome

Demographics
 Age (years; median, range) 63.5 (26–95)
 Male (number, percentage) 65/106 (61.3)
 Female (number, percentage) 41/106 (38.7)
Clinical information
 No comorbidity (number, percentage) 66/106 (62.3)
 Presence of ≥ 1 comorbidity 40/106 (37.7)
 Duration of symptoms at computed tomography (days; median, range) 5 (1–30)
Laboratory information
 White blood cell count (109/L) (median, range) 5.7 (1.9–29.7)
 Lymphocyte (%) (median, range) 18.8 (2.2–53.0)
 C-reactive protein (mg/L) (median, range) 4.94 (0.1–28.3)
Admitted/discharged from emergency department
 Admitted 97/106 (91.5%)
 Discharged from the emergency department 9/106 (8.5%)
Outcome
 Favourable 64/106 (60.4%)
 Adverse 42/106 (39.6%)
Outcome subgroups
 Need for mechanical ventilation 17/42 (40.5%)
 Death 25/42 (59.5%)